These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5134979)

  • 1. [Hansen L: action of thalidomide on a severe outburst].
    Duperrat B; Puissant A; Goudie ; David V; Saurat JM
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(3):291-2. PubMed ID: 5134979
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rapidly resolutive action of thalidomide on recurrences of leprosy].
    Degos R; Lortat-Jacob E; Civatte J; Daniel F
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(5):474-8. PubMed ID: 5987422
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thalidomide in leprosy reactions].
    Netto LS
    Rev Bras Med; 1967 Sep; 24(9):760-3. PubMed ID: 5618212
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thalidomide and lepromatous leprosy reaction].
    Jonquières ED; Mosto SJ; Brusco CM
    Arch Argent Dermatol; 1967 Sep; 17(3):279-86. PubMed ID: 5596976
    [No Abstract]   [Full Text] [Related]  

  • 5. [2 cases of anti-reactive ineffectiveness of thalidomide treatment of leprosy].
    Merklen FP; Cottenot F
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(6):738-9. PubMed ID: 5712976
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients.
    Chandorkar AG; Burte NP; Jadhav JH; Gade RK; Bulakh PM; Tayshete SN; Kale VM
    Indian J Lepr; 1984; 56(2):264-8. PubMed ID: 6548496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thalidomide in the treatment of leprosy reactions. 3 years of experience in Mexico].
    Latapí F; Saúl A; Gómez-Vidal M
    Gac Med Mex; 1969 Oct; 99(10):917-31. PubMed ID: 5363611
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of 2 new products, thalidomide and B. 663 on reactive forms of Hansen's disease].
    Languillon J
    Med Trop (Mars); 1969; 29(4):497-503. PubMed ID: 5403099
    [No Abstract]   [Full Text] [Related]  

  • 9. Unsatisfactory results with thalidomide as a specific treatment for leprosy.
    Sheskin J; Sagher F; Dorfman M; Schrader-Beielstein HW
    Isr J Med Sci; 1968; 4(4):901-4. PubMed ID: 5710961
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current state of thalidomide treatment of leprosy and leprosy reaction].
    Sheskin J; Sagher F
    Arch Klin Exp Dermatol; 1970; 237(1):312-6. PubMed ID: 4906813
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with thalidomide in 2 patients with acute lepromatous leprosy reactions].
    Hogerzeil LM; Simons RD
    Ned Tijdschr Geneeskd; 1966 Sep; 110(39):1722-3. PubMed ID: 5977696
    [No Abstract]   [Full Text] [Related]  

  • 12. [Leprous reaction and thalidomide. Results of treatment of 30 cases].
    Saul A
    Prensa Med Mex; 1969; 34(11):403-9. PubMed ID: 5381704
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlled follow-up assessment of the effect of thalidomide upon the ulnar nerve in leprosy.
    Magora A; Rozin R; Sagher F; Sheskin J; Gonen B
    Int J Lepr Other Mycobact Dis; 1971; 39(4):863-71. PubMed ID: 5170475
    [No Abstract]   [Full Text] [Related]  

  • 14. [Failure of thalidomide treatment in a case of leprous erythema multiforme].
    Duperrat B; Puissant A; Pringuet R; Revuz J; Lauret P; Ghezzi
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(6):736-7. PubMed ID: 5712975
    [No Abstract]   [Full Text] [Related]  

  • 15. [Supidimide, a non-teratogenic thalidomide analog for the treatment of leprosy reaction?].
    Sheskin J; Mückter H; Frankus E
    Hautarzt; 1983 Apr; 34(4):168-70. PubMed ID: 6853166
    [No Abstract]   [Full Text] [Related]  

  • 16. Supplies of thalidomide for use in leprosy.
    Loretti A; Barchi E
    Lepr Rev; 1986 Mar; 57(1):76-7. PubMed ID: 3702585
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of a double blind study of the influence of thalidomide on the lepra reaction.
    Sheskin J; Convit J
    Int J Lepr Other Mycobact Dis; 1969; 37(2):135-46. PubMed ID: 4900407
    [No Abstract]   [Full Text] [Related]  

  • 18. Thalidomide approved.
    Posit Aware; 1998; 9(5):16. PubMed ID: 11365882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of lepromatous erythema nodosum using chloramphenicol. Comparison with thalidomide. Statistical study from the Marchoux Institute].
    Saint-André P; Ferracci C; Baquillon G; Ridel PR; Boucher P
    Acta Leprol; 1981; (84):57-62. PubMed ID: 6797223
    [No Abstract]   [Full Text] [Related]  

  • 20. [Incorporation of thalidomide to the therapeutic arsenal of Hansen's disease (award of the Spanish Academy of Dermatology 1968)].
    Sheskin J
    Actas Dermosifiliogr; 1969; 60(3):57-72. PubMed ID: 5800285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.